Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 Life Science Investing
Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock Life Science Investing
FutureGen Industries Provides Shareholder Update on Expanded Investment Strategy in High-Growth Technology Sectors Psychedelics Investing
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer Life Science Investing
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call Life Science Investing
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026 Medical Device Investing
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings Life Science Investing
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format Life Science Investing
